The Cancer Registry of Norway Jan F Nygård Head of the IT-department.

Slides:



Advertisements
Similar presentations
High Resolution Italian studies Pamela Minicozzi Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione.
Advertisements

Advanced breast cancer
Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.
Nadya Dimitrova Marieta Petkova. 13 Regional cancer registries BNCR: -Established in 1952; cases a year; million population;
New Zealand Regional Cancer Networks Improved cancer control through increased regional collaboration.
EUROCHIP PILOT STUDIES. Collection of detailed clinical information for specific tumours Describing and comparing care in representative samples of cancer.
Oncology The study of cancer. What is cancer? Any malignant growth or tumor caused by abnormal and uncontrolled cell division May be a tumor but it doesn’t.
THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe
The End of the Disease Era Gero 302 Jan The Problem We now need to abandon disease as the focus for medical care. Clinical decisions should be made.
National Cancer Registry Luxembourg EUROCHIP-3 Meeting Ispra, 27 th February 2012 Olivier Collignon, PhD, Sophie Couffignal, MD, CRP-Santé.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Hallauer 06/20011 Outcome evaluation of an universal hepatitis B immunisation programme Johannes F. Hallauer M.D. Health Systems Research Charité, Humboldt.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
Documentation for Acute Care
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Evaluation of Electronic Radiotherapy Data for Quality Checking Cancer Registry Data Colin Fox (NICR) Richard Middleton (NICR) Denise Lynd (BCH – COIS)
Clinical Content Update: Cancer John Horton, M.B., Ch.B. October, 2004.
Cervical cancer screening problems and barriers in Latvia
Purposes and uses of cancer registration E.E.U. Akang Department of Pathology University College Hospital Ibadan, Nigeria.
Cancer Prevention in Taiwan
NATIONAL POPULATION BASED- CANCER REGISTRY- Dr. G.Z. Mutuma Principal Research Officer, Head, Non-Communicable Diseases Research Programme, Kenya Medical.
Discordance in Hormone Receptor and HER2 Status in Breast Cancer during Tumor Progression Lindstrom LS et al. Proc SABCS 2010;Abstract S3-5.
Quality Cancer Data The Vital Role of Cancer Registrars in the Fight against Cancer Saves Lives.
EUROCHIP - EUROpean Cancer Health Indicators Project A project supported by the European Commission Andrea Micheli 1, Paolo Baili 1, Carmen Martinez 2,
Born in Bradford Data Linkage David Bolus Head of Data Quality and Information Governance NHS Bradford and Airedale.
HOW TO CONTROL CANCER Putting Science into Practice.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
RARECARENet project High-resolution study in the Finnish Cancer Registry Maarit Leinonen Chief Medical Officer Finnish Cancer Registry, Helsinki.
Outcomes of screening mammography among women aged 40 to 43 Institute for Clinical Evaluative Sciences Toronto, Canada (2006)
Cancer. What is cancer? Simply put, cancer is cell division that happens uncontrollably. If a cell does not receive a signal to stop dividing, unchecked.
Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.
National Program of Cancer Registries
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
Breast Cancer in Ghana How are we going to ‘beat’ it? Prof J-N Clegg-Lamptey SAMF Launch.
Associated Web sites CustomizableMaps The Atlas On-Line.
Sandy Jones Public Health Advisor Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion April.
13 site specific articles 13 site specific articles Adult patients (age 15+) Adult patients (age 15+) Survival by subsite, tumour morphology, stage Survival.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
Dr Heather O Dickinson Department of Child Health University of Newcastle
BETTER CANCER CARE A Discussion Elizabeth Porterfield Head, NHS National Planning Team SGHD.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
National Cancer Intelligence Network data usage 17 November 2015 – Veronique Poirier – Principal Cancer Analyst – NCIN.
Chapter 7: Indexes, Registers, and Health Data Collection
Cancer Services Collaborative A Service Improvement Partnership between Cancer Networks, the National Cancer Programme and the NHS Modernisation Agency.
Vicki LaRue, CTR KCR Abstractor’s Training February 12,
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
INDICATORS OF HEALTH STATUS Burden of disease Disability Adjusted Life Year (DALY) Health status Morbidity Life expectancy Prevalence Mortality Incidence.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
National Cancer Registry of Ukraine
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
Malawi National Cancer Registry update SJD Chasimpha Malawi Cancer Symposium Lilongwe August, 2016.
UK Hospitalizations due to Stroke in Prostate Cancer Patients
Cancer prevention and early detection
Cancer prevention and early detection
Indiana State Cancer Registry
Population-Based Cancer Registries in the United States:
SWAG SSG Sarcoma Cancer Meeting
SCHS and Health Statistics
ESTIMATING THE EFFICIENCY OF THREE NATIONAL CANCER SCREENING PROGRAMMES USING THE POPULATION-BASED CANCER REGISTRY DATA IN SLOVENIA Vesna ZADNIK MD,
Trends in cancer Incidence in the Republic of Mauritius,
Incidence and Mortality of Childhood Cancer in China
Presentation transcript:

The Cancer Registry of Norway Jan F Nygård Head of the IT-department

Background >Population-based cancer registry with national coverage >150 employees >Compulsory reporting of cancer cases since 1951 from the clinical community >Personal identification number >Correct coding of multiple primary tumours >Follow up of patients for survival analysis >Correct assessment of the denominators for cancer rates through the population database >Linkage with other sources for comparisons between groups

Legislation >The Cancer Registry may without consent contain data relating to persons who have or have had cancer, precancerous conditions, or benign tumours in the central nervous system: >name and personal identity number >address and municipality of residence >the site of origin of the cancer >morphological diagnosis >spread at the time of diagnosis >metastases >relapses >basis for diagnosis (imaging diagnostics, histopathological examination, cytological material, other type of examination) >cancer treatment received by the data subject (patient), indications and contra-indications for treatment, method of treatment, as well as any complications or side-effects >date and cause of death

Organisation

Death Markers Symptoms Disease progression Prevention Screening Curative Treatment Palliative Long term surveillance Long term effects Diagnostic investigations Screening- programs for breast- and cervical cancer Birth Research at the Cancer Registry Cancer diagnose Janus biobank Clinical registries for selected cancers Incidence registry > Number of scientific papers published in 2009: 88

Cancer registration in Norway Pathology reports Death certificatesHospital patient administrative systems Clinical notifications

The Main database (since 1953) >Number Patients: >Number of diagnoses: >Number of notifications: >Number of new cases 2009: >Data quality ( ) >98.8 % complete for all types of cancers combined >93,9 % morphologically verified >0,9 % obtained from death certificate only (DCO). >Basis for the yearly publication “Cancer in Norway”

Trends, all cancer types combined

Clinical quality registries >The main database contains data related to the initial diagnosis >Several additional clinical databases connected to the main database are either already established or will soon be, with a focus on treatment and longitudinal data >Nordic Solid Tumors in children (NOPHO) database >Colorectal cancer database >Prostate cancer database >Lung cancer database >Ovarian cancer database >Breast cancer database >Malignant melanoma database >Lymphoma database

The integrated model for national clinical registries >Clinical registries have been established as an integrated part of the Cancer Registry of Norway for >Colorectal cancer >Prostate cancer >Malignant melanoma >Breast cancer

Clinical and descriptive research >Projects related to the different clinical registries >diagnostics, treatment and outcome quality >evaluation of cancer care >Time trend studies >Prediction of future cancer burden >Annual report: Cancer in Norway 2007: “Long-term survival of cancer patients in Norway ”

Example: Treatment of rectum cancer Key success factors: >Introduction of new operation method (TME) with nationwide training >Establishment of a clinical registry for rectum cancer within the Cancer Registry of Norway (CRN) >Close collaboration between CRN and the clinical community >Feedback to the hospitals on their results >Centralizing treatment Proportion of local recurrence %9 %

Use of MR in medical investigation by calendar time

Screening-related research >Evaluation of the mammography programme: mortality changes, biological features, health service logistics, quality of diagnostics and treatment >Vaccination against HPV infection of the cervix >Evaluation of the cervix screening programme: logistics, compliance, tests >Colorectal cancer screening: adenoma/cancer, life-style, quality of life, health economy, health services, laboratory studies

Important events in life, as seen by a cancer epidemiologist

Traditional cancer registration Focus of primary diagnosis K: Clinical report P: Patology report D: Death certificate

Principles of registration >1st hand information >Independence of information >Collect information as they occur >Coding and classification adhere to agreed international guidelines With regard to comparability, completeness, validity and timeliness

Traditional cancer registration (plus) Focus on time of primary diagnosis K: Clinical report P: Patology report D: Death certificate N: Patient register report

So what is the difference between a traditional cancer register and a clinical/quality register?

Cancer registration Clinical / quality - registries Diagnosis Start of primary treatment End of primary treatment Time of relapse Time of metastatic disease D: Diagnostic report S: Surgery report R: Radiotherapy C: Chemotherapy report H: Hormonal therapy report P: Patology report D: Death certificate N: Patient register report

Consequences for clinical and health services research >Quality indicators >Are patients diagnosed according to national guideslines >Are patients treated according to national guideslines >Regional differences? >Comparisons of treatment regiments Diagnosis Start of primary treatment End of primary treatment Time of relapse Time of metastatic disease